Establishment of cell-based reporter system for diagnosis of poxvirus infection

Journal of Virological Methods

Volumn 167, Issue 1, 2010, Pages 23-30

  Levy, Orly ^a   Oron, Chaya ^a   Paran, Nir ^a   Keysary, Avi ^a   Israeli, Ofir ^a   Yitzhaki, Shmuel ^a   Olshevsky, Udy ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Diagnosis; GFP; Luciferase; Neutralization; Poxvirus

Indexed keywords

GREEN FLUORESCENT PROTEIN; LUCIFERASE; NEUTRALIZING ANTIBODY;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HELA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOPOXVIRUS; POXVIRUS; POXVIRUS INFECTION; PRIORITY JOURNAL; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS TITRATION;

ANIMALS; BIOLOGICAL ASSAY; CHO CELLS; CRICETINAE; CRICETULUS; GENES, REPORTER; HELA CELLS; HUMANS; LUCIFERASES; MICROBIAL VIABILITY; POXVIRIDAE INFECTIONS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TIME FACTORS;

ORTHOPOXVIRUS; POXVIRIDAE;

EID: 77953026674     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.03.005     Document Type: Article

References (24)

1. Borges M.B.J., Kato S.E.M., Damaso C.R.A., Moussataché N., Freire M.d.S., Possos S.R.L., Nascimento J.P. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies. Biologicals 2008, 36:105-110.
2. Coonrod A., Li F.-Q., Horovitz M. On the mechanism of DNA transfection: efficient gene transfer without viruses. Gene Ther. 1997, 4:1313-1321.
3. Cutchins E., Warren J., Jones W.P. The antibody response to smallpox vaccination as measured by a tissue culture plaque method. J. Immunol. 1960, 85:275-283.
4. Davison A.J., Moss B. Structure of vaccinia virus early promoter. J. Mol. Biol. 1989, 210:749-769.
5. De Silva F.S., Moss B. Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and required all five known poxvirus replication factors. Virol. J. 2005, 10.1186/1743-422x-2-23.
6. Downie A.W., McCarthy K., Macdonald A., MacCallum F.O., Macrae A.D. Virus and virus antigen in the blood of smallpox patients, their significance in early diagnosis and prognosis. Lancet 1953, 25(July):164-166.
7. Earl L.B., Americo J.L., Moss B. Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein. J. Virol. 2003, 77:10684-10688.
8. Eyal O., Olshevsky U., Lustig S., Paran N., Halevy M., Schnider R.P., Zomber G., Fuchs P. Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera. J. Virol. Methods 2005, 130:15-21.
9. Gervaix A., West D., Leoni L.M., Richman D.D., Wong-Staal F., Corbeil J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4653-4658.
10. Hazelton P.R., Gelderblom H.R. Electron microscopy for rapid diagnosis of infectious agent in emergent situation. Emerg. Infect. Dis. 2003, 9:294-303.
11. Iro M., Witteveldt J., Angus A.G.N., Woerz I., Kaul A., Bartenschlager R., Patel A.H. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication. Antiviral Res. 2009, 83:148-155.
12. Johnson M.C., Damon I.K., Karem K.L. A rapid, high-throughput vaccinia virus neutralizing assay for testing smallpox vaccine efficacy based on detection of green fluorescence protein. J. Virol. Methods 2008, 150:15-20.
13. Katz J.B. The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titers. J. Biol. Stand. 1987, 15:389-392.
14. Kutrh A., Achenbach J., Miller L., Mackay I.M., Pauli G., Nitsche A. Orthopoxvirus detection in environmental specimens during suspected bioterror attacks: inhibitory influence of common household products. Appl. Environ. Microbiol. 2008, 74:32-37.
15. Manischewitz J., King L.R., Bleckwenn N.A., Shiloach J., Taffs R., Merchlinsky N.E., Mikolajczyk M.G., Clanton D.J., Monath T., Weltzin R.A., Scott D.E., Golding H. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J. Infect. Dis. 2003, 188:440-448.
16. Melamed S., Paran N., Kats L., Ben-Nathan D., Israeli T., Schneider P., Levin R., Lustig S. Tail scarification with Vaccinia virus Lister as a model for evauation of smallpox vaccine potency in mice. Vaccine 2007, 25:7743-7753.
17. Mitra A.C., Sarkar J.K., Mukherjee M.K. Virus content of smallpox scabs. Bull. WHO 1974, 51:106-107.
18. Nitsche A., Ellerbrok H., Pauli G. Detection of orthopoxvirus DNA by real-time PCR and identification of variola virus DNA by melting analysis. J. Clin. Microbiol. 2004, 42:1207-1213.
19. Nitsche A., Stern D., Ellerbrok H., Pauli G. Detection of infectious poxvirus particles. Emerg. Infect. Dis. 2006, 12:1139-1141.
20. Orr N., Forman M., Marcus H., Lustig S., Paran N., Grotto I. Clinical and Immune responses after revaccination of Israeli adults with the Lister strain of Vaccinia virus. J. Infect. Dis. 2004, 190(7):1295-1302.
21. Paran N., Suezer Y., Lustig S., Israely T., Schwantes A., Melamed S., Katz L., Preuß T., Hanschman K.-M., Kalinke U., Erez N., Levin R., Valan B., LÖwer J., Shafferman A., Sutter G. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provodes solid protection in murine model of human smallpox. J. Infect. Dis. 2009, 199:39-48.
22. Putkuri N., Piiparinen H., Vaheri A., Vapalahti O. Detection of human orthopoxvirus infections and differentiation of smallpox virus with real-time PCR. J. Med. Virol. 2009, 81:146-152.
23. Sarkar, et al. Bull. WHO 1973, 48:517-522.
24. Scaramozzino N., Ferrier-Rembert A., Favier A.L., Rothlisberger C., Richard S., Crance J.M., Meyer H., Garin D. Real-Time PCR to identify variola virus or other human pathogenic orthopox viruses. Clin. Chem. 2007, 53(4):606-613.